472 Results
New Program Will Boost Aspiring Clinician Scientists
Funding News Edition: March 16, 2023
Through its new Medical Scientist Partnership Program, NIH will sponsor predoctoral students pursuing both a clinical doctoral degree and a biomedical research doctoral degree.
Two Opportunities to Join NIH’s Centers for AIDS Research Network
Funding News Edition: March 16, 2023
The Centers for AIDS Research program fosters synergy and research coordination, supports emerging research opportunities, and promotes resource sharing among institutions that receive significant HIV/AIDS funding from NIH.
NIAID Solicitation Seeks Preclinical Animal, Animal-Replacement Models
Funding News Edition: March 16, 2023
Can your organization develop, refine, and use animal and animal replacement models to assess candidate therapeutics, vaccines, and diagnostics targeted at infectious diseases and generate difficult-to-source reagents requiring an in vivo model?
Leverage Your Expertise Towards Genomic Centers for Infectious Disease Program
Funding News Edition: March 16, 2023
Help us develop and advance approaches in genomic technologies, computational tools, and large-scale data analysis of human pathogens and their interactions with the host and microbiome.
A Checklist to Recount Study Design for Vertebrate Animal Research
Funding News Edition: March 16, 2023
Heed NIH's call to improve complete reporting of results of vertebrate animal and cephalopod experiments by using the Animal Research: Reporting of In Vivo Experiments checklist.
International Awards—Part II. Foreign Projects
Funding News Edition: March 16, 2023
Foreign applications need to propose talent, resources, populations, or environmental conditions not in the United States, e.g., access to a unique study population.
“I applied for a research grant using the FORMS-G application form set. I am now preparing a resubmission application. Which form set should I use?”
Funding News Edition: March 16, 2023
Stay on Top of SAM Renewals and Organizational Registrations
Funding News Edition: March 1, 2023
NIAID cannot provide grant funds to organizations with an expired System for Award Management (SAM) registration; this includes competing and noncompeting awards.

Develop Vaccine Candidates for Sexually Transmitted Infections (STIs)
Funding News Edition: March 1, 2023
This initiative will focus on advanced vaccine development for STI pathogens that have limited candidates in the product development pipeline: Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum.
Investigate Vaccine Formulations with HIV Immunogens and Adjuvants
Funding News Edition: March 1, 2023
NIAID is soliciting contract proposals from offerors capable of providing a broad range of services to investigate vaccine formulations with HIV immunogens and adjuvants.
Salary Cap and NRSA Stipend Levels Announced in Early 2023
Funding News Edition: March 1, 2023
Congress restricts the amount of direct salary paid to an individual under an HHS award. Effective January 1, 2023, the salary limitation is set at a rate of $212,100 for 100 percent effort.
Provide Feedback to Help NIH Evaluate Postdoctoral Research Training
Funding News Edition: March 1, 2023
Share your thoughts on the roles and responsibilities of academic postdocs, including challenges in recruitment, retention, and quality of life of postdoctoral trainees.
Inform NIH’s Strategy to Enhance Public Access to Research Results
Funding News Edition: March 1, 2023
NIH drafted a Public Access Plan that would alter the NIH Public Access Policy to reflect new priorities identified in a White House Office of Science and Technology Policy memorandum.
Before You Get Carried Away Planning a No-Cost Extension
Funding News Edition: March 1, 2023
In order to spend unobligated funds from an earlier budget period during a no-cost extension, absent automatic carryover authority, you first need to confirm NIAID’s prior approval of a carryover.
“I saw NIAID’s DEIA request for information, but I think I answered one of those already?”
Funding News Edition: March 1, 2023
Reviewing NIAID’s Application and Award Counts for FY 2022
Funding News Edition: February 15, 2023
We share the number of R01-equivalent and R21 applications that NIAID received in the previous fiscal year (FY) as well as how many awards NIAID made in turn.

New Initiative Focuses on Food Allergy Research
Funding News Edition: February 15, 2023
NIAID established the clinical trial network Consortium for Food Allergy Research to address concerns about the increasing incidence of food allergy and paucity of treatment options.
Administrative Supplement Supports Research Testing on Gender Measurement
Funding News Edition: February 15, 2023
The health conditions of interest to NIAID impact the health of sexual minority and majority populations, and the Institute endorses meaningful sexual orientation and gender identity measurement in research, clinical care, and administrative settings.
NIAID-Supported HIV Vaccine Trials Network Has New Specimens Available
Funding News Edition: February 15, 2023
The HIV Vaccine Trials Network (HVTN) invites outside investigators to apply to use Imbokodo/HVTN 705 participant specimens or study data to conduct independent scientific research. Respond by April 4, 2023.
Summary of January 2023 Advisory Council Meeting
Funding News Edition: February 15, 2023
NIAID Acting Director Dr. Hugh Auchincloss provided updates on HIV/AIDS, malaria, Ebola, a promising Marburg vaccine, universal flu vaccine efforts, non-viral asthma attacks, monoclonal antibodies to target Epstein-Barr virus, and human antibody response to vaccinations.
Contribute to NIAID’s Efforts on Diversity, Equity, Inclusion, and Accessibility (DEIA)
Funding News Edition: February 15, 2023
NIAID invites information and recommendations to enhance DEIA across the Institute’s funded activities, such as strategies to address any systematic and structural barriers to receiving NIAID research funding that may exist.
Prepare Your First Data Management and Sharing Plan
Funding News Edition: February 15, 2023
Start with NIH’s extensive guidance; a new page features sample data management and sharing plans and the frequently asked questions page explains how to account for data management and sharing in your budget.
International Awards—Part I. Determining Eligibility
Funding News Edition: February 15, 2023
The eligibility of a principal investigator differs from that of an institution. This is important in the context of fellowships and career development awards, where non-citizens may be working at U.S. institutions, or U.S. citizens may be working at international institutions.
Contact Us
Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.